Nuvectis Pharma, Inc. (NVCT)
NVCT Stock Price Chart
Explore Nuvectis Pharma, Inc. interactive price chart. Choose custom timeframes to analyze NVCT price movements and trends.
NVCT Company Profile
Discover essential business fundamentals and corporate details for Nuvectis Pharma, Inc. (NVCT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Feb 2022
Employees
13.00
Website
https://www.nuvectis.comCEO
Ron Bentsur
Description
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
NVCT Financial Timeline
Browse a chronological timeline of Nuvectis Pharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Nov 2025
EPS estimate is -$0.24.
Earnings released on 5 Aug 2025
EPS came in at -$0.30 falling short of the estimated -$0.25 by -20.00%.
Earnings released on 6 May 2025
EPS came in at -$0.27 surpassing the estimated -$0.30 by +10.00%.
Earnings released on 25 Feb 2025
EPS came in at -$0.36 falling short of the estimated -$0.28 by -28.57%.
Earnings released on 5 Nov 2024
EPS came in at -$0.24 surpassing the estimated -$0.26 by +7.69%.
Earnings released on 6 Aug 2024
EPS came in at -$0.26 matching the estimated -$0.26.
Earnings released on 7 May 2024
EPS came in at -$0.25 surpassing the estimated -$0.40 by +37.50%.
Earnings released on 5 Mar 2024
EPS came in at -$0.41 falling short of the estimated -$0.40 by -2.50%, while revenue for the quarter reached -$4.10M .
Earnings released on 8 Nov 2023
EPS came in at -$0.37 surpassing the estimated -$0.38 by +2.63%.
Earnings released on 9 Aug 2023
EPS came in at -$0.38 falling short of the estimated -$0.34 by -11.76%.
Earnings released on 10 May 2023
EPS came in at -$0.27 surpassing the estimated -$0.44 by +38.64%, while revenue for the quarter reached $4.10M .
Earnings released on 7 Mar 2023
EPS came in at -$0.48 falling short of the estimated -$0.38 by -26.32%, while revenue for the quarter reached $149.00K .
Earnings released on 8 Nov 2022
EPS came in at -$0.42 falling short of the estimated -$0.27 by -55.56%.
Earnings released on 5 Aug 2022
EPS came in at -$0.28 falling short of the estimated -$0.24 by -16.67%, while revenue for the quarter reached -$140.00 .
Earnings released on 10 May 2022
EPS came in at -$0.32 falling short of the estimated -$0.23 by -39.13%.
Earnings released on 7 Feb 2022
EPS came in at -$0.18 surpassing the estimated -$0.85 by +79.08%, while revenue for the quarter reached $4.00K .
Earnings released on 14 Jan 2022
EPS came in at -$0.40 .
Earnings released on 30 Jun 2021
EPS came in at -$0.47 .
Earnings released on 31 Mar 2021
EPS came in at -$0.00 .
NVCT Stock Performance
Access detailed NVCT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.